Organization

Eric Bernicker, MD

1 clinical trial

Clinical trial

ENSIGN: Phase II Window of Opportunity Trial of Stereotactic Body Radiation Therapy and In Situ Gene Therapy Followed by Nivolumab in Metastatic Squamous or Non-Squamous Non-Small Cell Lung Carcinoma and Metastatic Uveal Melanoma

Status: Terminated, Estimated PCD: 2020-11-05